汤臣倍健(300146)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300146 汤臣倍健

已收盘 02-09 15:00:00

{"stockData":{"symbol":"300146","market":"SZ","secType":"STK","nameCN":"汤臣倍健","latestPrice":12.43,"timestamp":1770620601000,"preClose":12.31,"halted":0,"volume":14234036,"delay":0,"changeRate":0.0097,"floatShares":1121000000,"shares":1692000000,"eps":0.4088,"marketStatus":"已收盘","change":0.12,"latestTime":"02-09 15:00:00","open":12.39,"high":12.47,"low":12.27,"amount":176000000,"amplitude":0.0162,"askPrice":12.44,"askSize":541,"bidPrice":12.43,"bidSize":84,"shortable":0,"etf":0,"ttmEps":0.4088,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770687000000},"marketStatusCode":5,"adr":0,"adjPreClose":12.31,"symbolType":"stock","openAndCloseTimeList":[[1770600600000,1770607800000],[1770613200000,1770620400000]],"highLimit":13.54,"lowLimit":11.08,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":1691677031,"isCdr":false,"pbRate":1.84,"roa":"--","peRate":30.406067,"roe":"8.12%","epsLYR":0.39,"committee":-0.586702,"marketValue":21028000000,"turnoverRate":0.0127,"status":0,"floatMarketCap":13932000000},"requestUrl":"/m/hq/s/300146","defaultTab":"news","newsList":[{"id":"2609530646","title":"汤臣倍健：公司产品均按照国家批准的保健功能进行合规标识与宣传","url":"https://stock-news.laohu8.com/highlight/detail?id=2609530646","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609530646?lang=zh_cn&edition=full","pubTime":"2026-02-06 11:33","pubTimestamp":1770348797,"startTime":"0","endTime":"0","summary":"根据国家市场监督管理总局的规定，目前允许保健食品声称的保健功能共24项，其中包括“有助于抗氧化”“有助于增强免疫力”等功能，尚未将“抗衰老”或“抵抗病毒”单独列为可声称的保健功能。公司产品目前均按照国家批准的保健功能进行合规标识与宣传。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020600015918.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300146","BK0107","BK0114","BK0042","BK0226","BK0028","BK0146"],"gpt_icon":0},{"id":"2606633215","title":"汤臣倍健：公司将持续加强客服人员产品培训与考核","url":"https://stock-news.laohu8.com/highlight/detail?id=2606633215","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606633215?lang=zh_cn&edition=full","pubTime":"2026-01-26 17:24","pubTimestamp":1769419450,"startTime":"0","endTime":"0","summary":"证券之星消息，汤臣倍健01月26日在投资者关系平台上答复投资者关心的问题。雪球平台用户“汤汤讲解员”非公司官方账号。公司将持续加强客服人员产品培训与考核。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600022721.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","300146","BK0114","BK0146","BK0107","BK0028","BK0226"],"gpt_icon":0},{"id":"2606218613","title":"汤臣倍健：截至2025年三季度末，孙惠刚已退出前十大股东","url":"https://stock-news.laohu8.com/highlight/detail?id=2606218613","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606218613?lang=zh_cn&edition=full","pubTime":"2026-01-26 16:24","pubTimestamp":1769415850,"startTime":"0","endTime":"0","summary":"证券之星消息，汤臣倍健(300146)01月26日在投资者关系平台上答复投资者关心的问题。投资者提问：我问一下前十大股东，孙惠刚现在持股多少？为什么十大股东里没有孙惠刚了？汤臣倍健回复：投资者您好！截至2025年三季度末，孙惠刚已退出前十大股东，具体情况可查阅公司2025年第三季度报告。感谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600016820.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","BK0146","BK0042","BK0028","BK0107","300146","BK0114"],"gpt_icon":0},{"id":"2606426587","title":"股市必读：汤臣倍健（300146）1月23日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2606426587","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606426587?lang=zh_cn&edition=full","pubTime":"2026-01-26 02:50","pubTimestamp":1769367016,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘，汤臣倍健报收于12.64元，上涨1.12%，换手率1.7%，成交量19.1万手，成交额2.4亿元。董秘最新回复投资者： 我是股东，同意前面投资者建议，公司应该生产功能性饮料，受众更广泛，审批周期也短，可以拓宽价值链，更好发挥公司品牌、技术、生产等协同优势。请董秘将此建议郑重提交董事长。当日关注点来自交易信息汇总：1月23日主力资金净流出461.39万元，游资资金净流出706.75万元，散户资金净流入1168.14万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600001244.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0107","BK0226","300146","BK0114","BK0028","BK0042"],"gpt_icon":0},{"id":"2604588771","title":"股市必读：汤臣倍健（300146）1月19日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2604588771","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604588771?lang=zh_cn&edition=full","pubTime":"2026-01-20 02:39","pubTimestamp":1768847948,"startTime":"0","endTime":"0","summary":"截至2026年1月19日收盘，汤臣倍健报收于12.35元，上涨1.15%，换手率1.2%，成交量13.43万手，成交额1.65亿元。董秘最新回复投资者： 董秘你好！公司本来就是做保健食品的这样有损公司形象及口啤。从细微小事上做到维护品牌形不伤害消费者。提高消费者对品牌的信任度和忠诚度。上述情况已反馈至业务部门。当日关注点来自交易信息汇总：1月19日主力资金净流入284.57万元，显示主力对汤臣倍健股票短期态度偏积极。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012000001004.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","BK0107","BK0146","BK0028","BK0114","BK0042","300146"],"gpt_icon":0},{"id":"2603607788","title":"汤臣倍健：已着手建立企业级AI智能体开发平台","url":"https://stock-news.laohu8.com/highlight/detail?id=2603607788","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603607788?lang=zh_cn&edition=full","pubTime":"2026-01-15 20:51","pubTimestamp":1768481503,"startTime":"0","endTime":"0","summary":"证券之星消息，汤臣倍健(300146)01月14日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司在那些方面应用了AI技术？汤臣倍健回复：投资者您好！公司积极探索AI赋能管理运营的路径及模式，已着手建立企业级AI智能体开发平台，发掘并稳步推进其在业务运营、研发创新、客户服务、管理提效、数据分析等多个场景应用。感谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011500038784.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0107","159819","BK0042","BK0226","BK0028","BK0114","300146","BK0146"],"gpt_icon":0},{"id":"2603369128","title":"汤臣倍健站在转型十字路口：传统模式承压与内部增长挑战","url":"https://stock-news.laohu8.com/highlight/detail?id=2603369128","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603369128?lang=zh_cn&edition=full","pubTime":"2026-01-14 17:42","pubTimestamp":1768383720,"startTime":"0","endTime":"0","summary":"　　近年来，随着消费习惯的快速变迁和行业格局的演变，国内膳食营养补充剂行业的竞争态势已截然不同。作为行业龙头，汤臣倍健在坚守与转型之间努力寻找平衡。　　公司正尝试通过调整资源投放、优化渠道策略来应对当前的挑战。在投资者交流中，汤臣倍健也提到功能食品和海外品牌的部分产品采取了委托加工模式。　　汤臣倍健站在转型的十字路口，其过往依赖药店渠道和经销商网络的增长逻辑正面临考验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-01-14/doc-inhhhnwt4012170.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0042","300146","BK0114","BK0146","BK0107","BK0028","BK0226"],"gpt_icon":0},{"id":"2603540355","title":"股市必读：汤臣倍健（300146）1月12日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2603540355","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603540355?lang=zh_cn&edition=full","pubTime":"2026-01-13 01:44","pubTimestamp":1768239852,"startTime":"0","endTime":"0","summary":"截至2026年1月12日收盘，汤臣倍健报收于12.48元，上涨1.63%，换手率2.06%，成交量23.1万手，成交额2.87亿元。董秘最新回复投资者： 董秘您好，上海凡迪基因科技有限公司是一家专注于基因检测服务的高新技术企业，其核心业务聚焦于临床和健康领域的基因检测，与贵公司有着紧密的合作关系。公司已于2022年将上述股权全部处置，目前未持有上海凡迪股份。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011300001452.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300146","BK0146","BK0107","BK0028","BK0226","BK0042","BK0114"],"gpt_icon":0},{"id":"2601480054","title":"股市必读：汤臣倍健（300146）1月7日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2601480054","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601480054?lang=zh_cn&edition=full","pubTime":"2026-01-08 01:04","pubTimestamp":1767805453,"startTime":"0","endTime":"0","summary":"截至2026年1月7日收盘，汤臣倍健报收于12.15元，下跌1.7%，换手率1.46%，成交量16.32万手，成交额2.0亿元。董秘最新回复投资者： 您好！贵司CEO林志成在央视微对话中说将很快落地能从源头靶向清除衰老细胞的抗衰新物质PCC1的产品，能给更多相关产品的介绍吗？现在落地进度到哪一步了？具体请以公司正式发布的产品上市信息为准。交易信息汇总资金流向1月7日主力资金净流出2594.09万元；游资资金净流入2102.07万元；散户资金净流入492.02万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010800000582.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0107","BK0114","BK0042","BK0146","BK0028","300146","BK0226"],"gpt_icon":0},{"id":"2593141732","title":"股市必读：汤臣倍健（300146）12月23日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2593141732","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593141732?lang=zh_cn&edition=full","pubTime":"2025-12-24 02:33","pubTimestamp":1766514790,"startTime":"0","endTime":"0","summary":"截至2025年12月23日收盘，汤臣倍健报收于12.02元，下跌1.15%，换手率1.16%，成交量12.98万手，成交额1.57亿元。董秘最新回复投资者： 尊敬的董秘，您好！2024年年报，短期借款激增至15.43亿元，年报显示是“已贴现未到期商业汇票”，请问这是质押的应收账款吗？上述主要系公司基于整体资金安排进行票据贴现业务所致，公司无应收账款质押情形。当日关注点来自交易信息汇总：12月23日主力资金净流出1099.32万元，散户资金净流入1564.95万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122400001023.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0042","BK0107","300146","BK0226","BK0114","BK0146"],"gpt_icon":0},{"id":"2593462320","title":"汤臣倍健：公司无应收账款质押情形","url":"https://stock-news.laohu8.com/highlight/detail?id=2593462320","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593462320?lang=zh_cn&edition=full","pubTime":"2025-12-23 15:06","pubTimestamp":1766473579,"startTime":"0","endTime":"0","summary":"证券之星消息，汤臣倍健(300146)12月23日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘，您好！2024年年报，短期借款激增至15.43亿元，年报显示是“已贴现未到期商业汇票”，请问这是质押的应收账款吗？如果是，为什么“应收账款”科目仅有1.65亿？是遗漏了吗？激增这么多借款的原因是什么？谢谢！汤臣倍健回复：投资者您好！上述主要系公司基于整体资金安排进行票据贴现业务所致，公司无应收账款质押情形。感谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122300018874.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0107","BK0114","BK0042","BK0146","BK0028","300146","BK0226"],"gpt_icon":0},{"id":"2592920997","title":"汤臣倍健：坚持差异化战略打造产品科技力","url":"https://stock-news.laohu8.com/highlight/detail?id=2592920997","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592920997?lang=zh_cn&edition=full","pubTime":"2025-12-18 15:06","pubTimestamp":1766041587,"startTime":"0","endTime":"0","summary":"证券之星消息，汤臣倍健12月18日在投资者关系平台上答复投资者关心的问题。差异化是用户需求而其它企业没能满足的东西，而非仅仅是与众不同。没有差异化产品的商业模式基本不是好的商业模式。公司坚持执行差异化战略，在全球范围内科学甄选优质原料，深入开展自有知识产权原料、新功能和重功能创新产品开发，持续打造产品科技力和差异化竞争优势。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121800017388.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0042","BK0107","300146","BK0226","BK0114","BK0146"],"gpt_icon":0},{"id":"2590037861","title":"【机构调研记录】长盛基金调研汤臣倍健、博苑股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2590037861","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590037861?lang=zh_cn&edition=full","pubTime":"2025-12-10 08:05","pubTimestamp":1765325146,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及12月9日披露的机构调研信息，长盛基金近期对2家上市公司进行了调研，相关名单如下：1）汤臣倍健 调研纪要：公司聚焦主业，推动长期有质量发展。第四季度净利润受费用投放、奖金计提等影响。2）博苑股份 调研纪要：公司精细化学品主要包括碘化物、发光材料、六甲基二硅氮烷和贵金属催化剂，其中碘化物为营收核心。2025年12月11日将解除限售19,630,000股，目前未收到股东减持计划通知。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121000004481.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0226","301617","BK0107","BK0146","300146","BK0042","BK0114","BK0229"],"gpt_icon":0},{"id":"2590121143","title":"汤臣倍健：第四季度业绩受销售活动安排影响","url":"https://stock-news.laohu8.com/highlight/detail?id=2590121143","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590121143?lang=zh_cn&edition=full","pubTime":"2025-12-09 18:12","pubTimestamp":1765275130,"startTime":"0","endTime":"0","summary":"证券之星消息，汤臣倍健12月09日在投资者关系平台上答复投资者关心的问题。另外，为什么过去几年，每年公司Q4都会出现业绩下滑？谢谢汤臣倍健回复：投资者您好！公司坚持规范信息披露，严格遵守法律法规的有关规定管理未公开信息，不存在内幕信息泄露或违反公平信披原则等违规情形。公司第四季度业绩受销售活动安排、市场费用投放节奏、奖金计提和费用结算等因素影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120900029030.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0107","BK0042","BK0226","BK0028","BK0114","300146","BK0146"],"gpt_icon":0},{"id":"2586246182","title":"11月27日汤臣倍健发生1笔大宗交易 成交金额230.14万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586246182","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586246182?lang=zh_cn&edition=full","pubTime":"2025-11-27 17:41","pubTimestamp":1764236517,"startTime":"0","endTime":"0","summary":"证券之星消息，11月27日汤臣倍健发生大宗交易，交易数据如下：大宗交易成交价格12.44元，相对当日收盘价溢价1.8%，成交18.5万股，成交金额230.14万元，买方营业部为光大证券股份有限公司宁波柳汀街证券营业部，卖方营业部为光大证券股份有限公司宁波柳汀街证券营业部。近三个月该股共发生2笔大宗交易，合计成交3709.0手，折价成交1笔，溢价成交1笔。截至2025年11月27日收盘，汤臣倍健报收于12.22元，下跌0.65%，换手率1.03%，成交量11.52万手，成交额1.42亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112700025876.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0146","BK0226","BK0107","BK0114","300146","BK0028"],"gpt_icon":0},{"id":"2584921736","title":"股市必读：汤臣倍健（300146）11月18日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2584921736","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584921736?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:04","pubTimestamp":1763571858,"startTime":"0","endTime":"0","summary":"截至2025年11月18日收盘，汤臣倍健报收于12.7元，上涨0.79%，换手率2.25%，成交量25.27万手，成交额3.2亿元。当日关注点来自交易信息汇总：11月18日主力资金净流出1165.23万元，散户资金净流入394.8万元。来自机构调研要点：主品牌“汤臣倍健”定位全系列覆盖全人群，“健力多”与“lifespace”营收占比均已超10%。行业增量来自渗透率提升与新增人群扩容，VDS行业仍具增长空间。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112000000453.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0226","BK0107","300146","BK0114","BK0028","BK0146"],"gpt_icon":0},{"id":"2584995365","title":"汤臣倍健：有知名机构正圆投资参与的多家机构于11月18日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2584995365","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584995365?lang=zh_cn&edition=full","pubTime":"2025-11-19 10:02","pubTimestamp":1763517749,"startTime":"0","endTime":"0","summary":"证券之星消息，2025年11月18日汤臣倍健发布公告称国盛证券陈熠、东吴证券邓洁、财通证券张立、易方达基金易俊何、中科沃土基金彭上、建信养老官忠涛、长江自营高辰星、广发自营高峰、正圆投资冯荃晴于2025年11月18日调研我司。汤臣倍健主营业务：膳食营养补充剂的研发、生产和销售。该股最近90天内共有7家机构给出评级，买入评级2家，增持评级4家，中性评级1家；过去90天内机构目标均价为14.25。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111900008869.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0107","BK0226","300146","BK0042","BK0114","BK0146","BK0028"],"gpt_icon":0},{"id":"2584660270","title":"股市必读：汤臣倍健（300146）11月14日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2584660270","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584660270?lang=zh_cn&edition=full","pubTime":"2025-11-17 01:17","pubTimestamp":1763313430,"startTime":"0","endTime":"0","summary":"截至2025年11月14日收盘，汤臣倍健报收于12.72元，下跌2.53%，换手率2.37%，成交量26.54万手，成交额3.42亿元。董秘最新回复投资者： 给公司提个建议：买了你们家儿童增高产品，但小朋友经常忘记按时吃，大人也不可能老提醒，所以，建议针对小朋友的营养健康产品，最好能配搭提供一个“提醒功能”的小电子玩具。每天提醒小朋友自觉服用。交易信息汇总资金流向11月14日主力资金净流出3219.86万元；游资资金净流入1697.62万元；散户资金净流入1522.25万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111700000469.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0107","BK0114","BK0042","BK0146","BK0028","300146","BK0226"],"gpt_icon":0},{"id":"2583081540","title":"中原证券：运动营养市场为“基数小、增速快”的蓝海 关注汤臣倍健(300146.SZ)等基本面变化","url":"https://stock-news.laohu8.com/highlight/detail?id=2583081540","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583081540?lang=zh_cn&edition=full","pubTime":"2025-11-14 11:20","pubTimestamp":1763090429,"startTime":"0","endTime":"0","summary":"整体看，运动营养市场呈现“基数小、增速快”的蓝海特征。A股上市公司中涉足运动营养的上市公司主要包括康比特、汤臣倍健和西王食品，建议关注这些上市公司的基本面变化。中国运动营养市场的增长远快于全球水平：2024年中国运动营养食品市场规模为97.1亿元，预计2030年增至209.3亿元，年均增长11.56%。与国际市场不同，在中国运动营养的市场集中度较高根据核算，截至2024年中国运动营养市场CR3达到70%，头部企业包括西王食品、康比特和汤臣倍健等。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1369190.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0107","BK0226","300146","BK0042","BK0201","BK0114","601375","BK0146","BK0276","BK0028"],"gpt_icon":0},{"id":"2583165925","title":"股市必读：汤臣倍健（300146）11月13日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2583165925","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583165925?lang=zh_cn&edition=full","pubTime":"2025-11-14 03:32","pubTimestamp":1763062335,"startTime":"0","endTime":"0","summary":"截至2025年11月13日收盘，汤臣倍健报收于13.05元，上涨1.08%，换手率2.26%，成交量25.31万手，成交额3.27亿元。膳食营养补充剂行业发展将受益于国民健康意识提升、人口老龄化趋势加深及新生代消费群体扩容等。当日关注点来自交易信息汇总：11月13日主力资金净流入565.84万元，显示主力对个股呈积极介入态势。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111400003148.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0107","BK0114","300146","BK0226","BK0146","BK0042","BK0028"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1770623504254,"stockEarnings":[{"period":"1week","weight":0.0115},{"period":"1month","weight":0.0132},{"period":"3month","weight":-0.0152},{"period":"6month","weight":0.0327},{"period":"1year","weight":0.1136},{"period":"ytd","weight":0.025}],"compareEarnings":[{"period":"1week","weight":-0.0127},{"period":"1month","weight":-0.0049},{"period":"3month","weight":0.017},{"period":"6month","weight":0.1184},{"period":"1year","weight":0.243},{"period":"ytd","weight":0.0244}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"汤臣倍健股份有限公司","boardCode":"AI0014","boardName":"食品制造业","stockholders":"71105人(较上一季度减少0.14%)","perCapita":"15762股","listingDate":"2010-12-15","address":"广东省珠海市金湾区三灶科技工业园星汉路19号","registeredCapital":"169167万元","survey":"　　汤臣倍健股份有限公司的主营业务是膳食营养补充剂的生产销售。公司的主要产品是片剂、粉剂、胶囊、其他。截至报告期末，公司获得134项原料及配方等发明专利。","listedPrice":110},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"汤臣倍健(300146)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供汤臣倍健(300146)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"汤臣倍健,300146,汤臣倍健股票,汤臣倍健股票老虎,汤臣倍健股票老虎国际,汤臣倍健行情,汤臣倍健股票行情,汤臣倍健股价,汤臣倍健股市,汤臣倍健股票价格,汤臣倍健股票交易,汤臣倍健股票购买,汤臣倍健股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"汤臣倍健(300146)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供汤臣倍健(300146)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}